Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Challenges and Risks. Edition No. 1

VDM Publishing House, Sep 2009, Pages: 396


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

This thesis is aimed at investigating the patterns of injecting drug use and hepatitis C (HCV).Traditional psychological models are unable to explain why people cannot avoid risk behaviour in certain situations. By contrast, the harm reduction model, despite being relatively poorly theorised, can be seen as useful in giving an account of behaviour change, with particular reference to HCV-related risk behaviour.The thesis uses a self-reported questionnaire to identify risk behaviours for HCV transmission and to examine their relationships to demographic and social factors. A survey of Injecting Drug Users(IDUs) attending needle and syringe programs in the Sydney metropolitan area and members of NSW Users & AIDS Association yielded 336 responses. The results suggest that more than two thirds of the subjects had adopted some measures to avoid risky situations.Unavailability of needles and syringes was an important factor in determining IDUs' preparedness to share needles and syringes. Risky injecting practices are linked to stigmatisation of injecting drug use which obstructs users' access to information and clean equipment and the lack of reliable information concerning the transmission of hepatitis C.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds